Immunic Inc. (IMUX) Reports FY21 EPS of ($3.93)

Immunic Inc. (NASDAQ: IMUX) reported FY21 EPS of ($3.93). Revenue for the quarter came in at $0 , versus $0 reported last year.

For earnings history and earnings-related data on Immunic Inc. (IMUX) click here.

You May Also Be Interested In

• Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
• Oppenheimer Starts Viatris (VTRS) at Outperform
• Activist Jana Partners calls for Six Flags sale - WSJ